These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9774487)

  • 1. The analgesic effects of tryptophan and its metabolites in the rat.
    Heyliger SO; Goodman CB; Ngong JM; Soliman KF
    Pharmacol Res; 1998 Oct; 38(4):243-50. PubMed ID: 9774487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large amounts of picolinic acid are lethal but small amounts increase the conversion of tryptophan-nicotinamide in rats.
    Shibata K; Fukuwatari T
    J Nutr Sci Vitaminol (Tokyo); 2014; 60(5):334-9. PubMed ID: 25744422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of kynurenine-induced seizures by picolinic, kynurenic and xanthurenic acids.
    Lapin IP
    J Neural Transm; 1983; 56(2-3):177-85. PubMed ID: 6864208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synergism of picrotoxin with the endogenous convulsants kynurenine and quinolinic acid and its antagonism with their antagonists].
    Lapin IP; Ryzhov IV
    Farmakol Toksikol; 1985; 48(6):13-7. PubMed ID: 3002845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
    Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
    Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexity of in vivo induction of tryptophan oxygenase and tyrosine aminotransferase: effects of tryptophan metabolites.
    Hardeland R
    Comp Biochem Physiol B; 1972 Jan; 41(1):39-44. PubMed ID: 4403889
    [No Abstract]   [Full Text] [Related]  

  • 7. Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid.
    Kanchanatawan B; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Ormstad H; Anderson G; Maes M
    Mol Neurobiol; 2018 Feb; 55(2):1524-1536. PubMed ID: 28181189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of tryptophan metabolites on brain 5-hydroxytryptamine metabolism.
    Green AR; Curzon G
    Biochem Pharmacol; 1970 Jun; 19(6):2061-8. PubMed ID: 4254787
    [No Abstract]   [Full Text] [Related]  

  • 9. Quinolinate-induced cortical cholinergic damage: modulation by tryptophan metabolites.
    Jhamandas K; Boegman RJ; Beninger RJ; Bialik M
    Brain Res; 1990 Oct; 529(1-2):185-91. PubMed ID: 2149296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a single analytical method for the determination of tryptophan, and its kynurenine metabolites in rat plasma.
    Möller M; Du Preez JL; Harvey BH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun; 898():121-9. PubMed ID: 22608808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of urinary tryptophan metabolites in the etiology of bladder cancer.
    Bryan GT
    Am J Clin Nutr; 1971 Jul; 24(7):841-7. PubMed ID: 4934541
    [No Abstract]   [Full Text] [Related]  

  • 12. Pentafluorobenzylation method for quantification of acidic tryptophan metabolites using electron capture negative ion mass spectrometry.
    Naritsin DB; Boni RL; Markey SP
    Anal Chem; 1995 Mar; 67(5):863-70. PubMed ID: 7762823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice.
    Lapin IP
    J Neural Transm; 1978; 42(1):37-43. PubMed ID: 641543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in membrane fluidity induced by tryptophan and its metabolites.
    Rudzite V; Jurika E; Jirgensons J
    Adv Exp Med Biol; 1999; 467():353-67. PubMed ID: 10721077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the antioxidant properties of tryptophan and its metabolites in in vitro assay.
    Nayak BN; Buttar HS
    J Complement Integr Med; 2016 Jun; 13(2):129-36. PubMed ID: 26641976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An expanding range of targets for kynurenine metabolites of tryptophan.
    Stone TW; Stoy N; Darlington LG
    Trends Pharmacol Sci; 2013 Feb; 34(2):136-43. PubMed ID: 23123095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure.
    Pawlak D; Tankiewicz A; Mysliwiec P; Buczko W
    Nephron; 2002 Mar; 90(3):328-35. PubMed ID: 11867954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-infectious activity of tryptophan metabolites in the L-tryptophan-L-kynurenine pathway.
    Narui K; Noguchi N; Saito A; Kakimi K; Motomura N; Kubo K; Takamoto S; Sasatsu M
    Biol Pharm Bull; 2009 Jan; 32(1):41-4. PubMed ID: 19122278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kynurenine pathway metabolism following prenatal KMO inhibition and in Mecp2
    Forrest CM; Kennedy PG; Rodgers J; Dalton RN; Turner C; Darlington LG; Cobb SR; Stone TW
    Neurochem Int; 2016 Nov; 100():110-119. PubMed ID: 27623092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
    Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
    Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.